Literature DB >> 16772003

Stronger host response per parasitized erythrocyte in Plasmodium vivax or ovale than in Plasmodium falciparum malaria.

Christoph Josef Hemmer1, Friedrich Georg Ernst Holst, Peter Kern, Collins Batsirai Chiwakata, Manfred Dietrich, Emil Christian Reisinger.   

Abstract

OBJECTIVE AND METHODS: Fever tends to start at a lower level of parasitemia in Plasmodium vivax or ovale than in P. falciparum malaria, but hyperparasitemia and complications are more likely to occur in P. falciparum malaria. Therefore, we compared the relationship between parasitemia and host response parameters before therapy in 97 patients with P. faciparum malaria (18 with complications), and 28 with P. vivax or ovale malaria.
RESULTS: In both types of malaria, parasitemia correlated with blood levels of tumour necrosis factor alpha (TNF-alpha), lactate dehydrogenase (LDH), Thrombin-antithrombin III (TAT) and elastase, and these parameters were higher in P. falciparum malaria than in P. vivax or ovale malaria. In contrast, the ratios of TNF-alpha, TAT, elastase, and LDH per parasitized erythrocyte were higher in P. vivax or ovale malaria than in uncomplicated P. falciparum malaria. They were lowest in complicated disease. Multivariate regression analysis confirmed that parasitemia did not affect these differences.
CONCLUSION: The host response may reach full strength at lower parasitemia in Plasmodium vivax or ovale, than in P. falciparum malaria. With hyperparasitemia in P. falciparum malaria, the host response seems to be unable to control parasite multiplication.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16772003     DOI: 10.1111/j.1365-3156.2006.01635.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  43 in total

1.  Characterization of platelet count and platelet indices and their potential role to predict severity in malaria.

Authors:  Pranjal Gupta; Vasudev Guddattu; Kavitha Saravu
Journal:  Pathog Glob Health       Date:  2019-04-09       Impact factor: 2.894

2.  Prevention and treatment of vivax malaria.

Authors:  J Kevin Baird; Eli Schwartz; Stephen L Hoffman
Journal:  Curr Infect Dis Rep       Date:  2007-01       Impact factor: 3.725

3.  The unusual presentation of a usual organism - the changing spectrum of the clinical manifestations of Plasmodium vivax malaria in children: a retrospective study.

Authors:  Shobha Sharma; Kailash Chandra Aggarwal; Shivani Deswal; Deepak Raut; Neelam Roy; Rohit Kapoor
Journal:  J Clin Diagn Res       Date:  2013-09-10

Review 4.  Resistance to therapies for infection by Plasmodium vivax.

Authors:  J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

5.  Malaria in Brazil: an overview.

Authors:  Joseli Oliveira-Ferreira; Marcus V G Lacerda; Patrícia Brasil; José L B Ladislau; Pedro L Tauil; Cláudio Tadeu Daniel-Ribeiro
Journal:  Malar J       Date:  2010-04-30       Impact factor: 2.979

Review 6.  Respiratory Complications of Plasmodium vivax Malaria: Systematic Review and Meta-Analysis.

Authors:  Fernando Val; Kim Machado; Lisiane Barbosa; Jorge Luis Salinas; André Machado Siqueira; Maria Graças Costa Alecrim; Hernando Del Portillo; Quique Bassat; Wuelton Marcelo Monteiro; Marcus Vinícius Guimarães Lacerda
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

Review 7.  Potential immune mechanisms associated with anemia in Plasmodium vivax malaria: a puzzling question.

Authors:  Thiago Castro-Gomes; Luiza C Mourão; Gisely C Melo; Wuelton M Monteiro; Marcus V G Lacerda; Érika M Braga
Journal:  Infect Immun       Date:  2014-08-04       Impact factor: 3.441

Review 8.  New medicines to improve control and contribute to the eradication of malaria.

Authors:  Timothy N C Wells; Pedro L Alonso; Winston E Gutteridge
Journal:  Nat Rev Drug Discov       Date:  2009-10-16       Impact factor: 84.694

9.  Neopterin and procalcitonin are suitable biomarkers for exclusion of severe Plasmodium falciparum disease at the initial clinical assessment of travellers with imported malaria.

Authors:  René te Witt; Marlies E van Wolfswinkel; Pieter L Petit; Jaap J van Hellemond; Rob Koelewijn; Alex van Belkum; Perry J J van Genderen
Journal:  Malar J       Date:  2010-09-14       Impact factor: 2.979

Review 10.  Vivax malaria: neglected and not benign.

Authors:  Ric N Price; Emiliana Tjitra; Carlos A Guerra; Shunmay Yeung; Nicholas J White; Nicholas M Anstey
Journal:  Am J Trop Med Hyg       Date:  2007-12       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.